Femasys Inc. Selling and Marketing Expense
Femasys Inc. (FEMY) reported Selling and Marketing Expense of $1.29 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-08-14
- Femasys Inc. selling and marketing expense for the quarter ending 2026-06-30 was $1.29M, a 31.37% increase year-over-year.
- Femasys Inc. selling and marketing expense for the quarter ending 2026-03-31 was $1.32M, a 44.82% increase year-over-year.
- Femasys Inc. selling and marketing expense for the quarter ending 2025-12-31 was $1.41M, a 18.96% increase year-over-year.
- Femasys Inc. selling and marketing expense for the quarter ending 2025-09-30 was $1.14M, a 27.25% decline year-over-year.
- Femasys Inc. selling and marketing expense for fiscal 2025 was $4.44M, a 10.26% increase from fiscal 2024.
- Femasys Inc. selling and marketing expense for fiscal 2024 was $4.03M, a 519.90% increase from fiscal 2023.
- Femasys Inc. selling and marketing expense for fiscal 2023 was $650.13K, a 16.33% increase from fiscal 2022.
- Femasys Inc. selling and marketing expense for fiscal 2022 was $558.85K, a 167.73% increase from fiscal 2021.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 6 month | Selling and Marketing Expense 9 month | Selling and Marketing Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.29M 10-Q · filed 2026-08-14 | $2.61M 10-Q · filed 2026-08-14 | $4.02M derived: sum of 3 quarters · filed 2026-08-14 | $5.16M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $1.32M 10-Q · filed 2026-05-08 | $2.72M derived: sum of 2 quarters · filed 2026-05-08 | $3.87M derived: sum of 3 quarters · filed 2026-05-08 | $4.85M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $2.55M derived: sum of 2 quarters · filed 2026-03-31 | $3.54M derived: sum of 3 quarters · filed 2026-08-14 | $4.44M 10-K · filed 2026-03-31 |
| 2025-09-30 | $1.14M 10-Q · filed 2025-11-14 | $2.13M derived: sum of 2 quarters · filed 2026-08-14 | $3.04M 10-Q · filed 2025-11-14 | $4.22M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $984.98K 10-Q · filed 2026-08-14 | $1.89M 10-Q · filed 2026-08-14 | $3.08M derived: sum of 3 quarters · filed 2026-08-14 | $4.65M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $908.57K 10-Q · filed 2026-05-08 | $2.09M derived: sum of 2 quarters · filed 2026-05-08 | $3.66M derived: sum of 3 quarters · filed 2026-05-08 | $4.64M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $2.75M derived: sum of 2 quarters · filed 2026-03-31 | $3.73M derived: sum of 3 quarters · filed 2026-03-31 | $4.03M 10-K · filed 2026-03-31 |
| 2024-09-30 | $1.57M 10-Q · filed 2025-11-14 | $2.55M derived: sum of 2 quarters · filed 2025-11-14 | $2.85M 10-Q · filed 2025-11-14 | $3.05M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $975.19K 10-Q · filed 2025-08-08 | $1.28M 10-Q · filed 2025-08-08 | $1.48M derived: sum of 3 quarters · filed 2025-08-08 | $1.55M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $300.49K 10-Q · filed 2025-05-08 | $505.94K derived: sum of 2 quarters · filed 2025-05-08 | $576.82K derived: sum of 3 quarters · filed 2025-05-08 | $705.72K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $205.45K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $276.33K derived: sum of 2 quarters · filed 2025-03-27 | $405.23K derived: sum of 3 quarters · filed 2025-03-27 | $650.13K 10-K · filed 2025-03-27 |
| 2023-09-30 | $70.88K 10-Q · filed 2024-11-12 | $199.78K derived: sum of 2 quarters · filed 2024-11-12 | $444.68K 10-Q · filed 2024-11-12 | $781.12K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $128.90K 10-Q · filed 2024-08-08 | $373.80K 10-Q · filed 2024-08-08 | $710.23K derived: sum of 3 quarters · filed 2024-08-08 | $800.61K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $244.90K 10-Q · filed 2024-05-09 | $581.33K derived: sum of 2 quarters · filed 2024-05-09 | $671.71K derived: sum of 3 quarters · filed 2024-05-09 | $734.88K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $336.44K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $426.81K derived: sum of 2 quarters · filed 2024-03-28 | $489.99K derived: sum of 3 quarters · filed 2024-03-28 | $558.85K 10-K · filed 2024-03-28 |
| 2022-09-30 | $90.37K 10-Q · filed 2023-11-14 | $153.55K derived: sum of 2 quarters · filed 2023-11-14 | $222.41K 10-Q · filed 2023-11-14 | $343.22K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $63.18K 10-Q · filed 2023-08-10 | $132.04K 10-Q · filed 2023-08-10 | $252.84K derived: sum of 3 quarters · filed 2023-08-10 | $296.13K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $68.86K 10-Q · filed 2023-05-11 | $189.67K derived: sum of 2 quarters · filed 2023-07-24 | $232.95K derived: sum of 3 quarters · filed 2023-07-24 | $254.78K derived: sum of 4 quarters · filed 2023-07-24 |
| 2021-12-31 | $120.80K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-07-24 | $164.09K derived: sum of 2 quarters · filed 2023-07-24 | $185.92K derived: sum of 3 quarters · filed 2023-07-24 | $208.74K 10-K/A · filed 2023-07-24 |
| 2021-09-30 | $43.28K 10-Q · filed 2022-11-10 | $65.11K derived: sum of 2 quarters · filed 2022-11-10 | $87.93K 10-Q · filed 2022-11-10 | $116.57K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $21.83K 10-Q · filed 2022-08-10 | $44.65K 10-Q · filed 2022-08-10 | $73.28K derived: sum of 3 quarters · filed 2022-08-10 | $104.29K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $22.82K 10-Q · filed 2022-05-11 | $51.45K derived: sum of 2 quarters · filed 2022-05-11 | $82.47K derived: sum of 3 quarters · filed 2022-05-11 | $95.85K derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $28.64K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $59.65K derived: sum of 2 quarters · filed 2022-03-24 | $73.03K derived: sum of 3 quarters · filed 2022-03-24 | $310.22K 10-K · filed 2022-03-24 |
| 2020-09-30 | $31.01K 10-Q · filed 2021-11-12 | $44.39K derived: sum of 2 quarters · filed 2021-11-12 | $281.58K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $13.38K 10-Q · filed 2021-08-11 | $250.57K 10-Q · filed 2021-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |